TRACON Pharmaceuticals, Inc. Patent Applications Rejected
6 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2019-09-30: Application 16588543; Invention Endoglin Antibodies; Applicant Tracon Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2018-10-01: Application 16148571; Invention ANTI-ENDOGLIN ANTIBODIES AND USES THEREOF; Applicant Tracon Pharmaceuticals, Inc.; Status Abandoned -- Failure to Pay Issue Fee.
- 2018-07-13: Application 16034658; Invention Antibody Formulations and Uses Thereof; Applicant Tracon Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2018-02-28: Application 15907505; Invention Endoglin Antibodies; Applicant Tracon Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | 16588543 | Endoglin Antibodies | Tracon Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20200048360A1 | Charles P. Theuer Maximiliano Vasquez | United States United States | |
| 2018-10-01 | 16148571 | ANTI-ENDOGLIN ANTIBODIES AND USES THEREOF | Tracon Pharmaceuticals, Inc. | Abandoned -- Failure to Pay Issue Fee | US20190016815A1 | Charles Theuer | United States | LOCKARD, JON MCCLELLAND |
| 2018-07-13 | 16034658 | Antibody Formulations and Uses Thereof | Tracon Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180311359A1 | Suzanne Benedict Mark Cornell Manning Brian M. Murphy Sharon Real Charles Theuer | United States United States United States United States United States | KIM, YUNSOO |
| 2018-02-28 | 15907505 | Endoglin Antibodies | Tracon Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180194854A1 | Charles P. Theuer Maximiliano Vasquez | United States United States | NATARAJAN, MEERA |
| 2017-07-12 | 15648027 | POTENTIATION OF ANTI-CANCER ACTIVITY THROUGH COMBINATION THERAPY WITH BER PATHWAY INHIBITORS | Tracon Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170312233A1 | Charles Theuer | United States | LEE, ANDREW P |
| 2012-10-15 | 13640466 | POTENTIATION OF ANTI-CANCER ACTIVITY THROUGH COMBINATION THERAPY WITH BER PATHWAY INHIBITORS | Tracon Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20130030237A1 | Charles Theuer | United States | LEE, ANDREW P |